Attenuated interleukin-8/leukocyte immunoresponse... (2011 study) Skip to main content
Pilot Study Human immunology 2011

Attenuated interleukin-8/leukocyte immunoresponse in preterm infants compared with term infants hospitalized with respiratory syncytial virus bronchiolitis: a pilot study.

Assefa D, Amin N, Dozor AJ, Parton LA, Human immunology, 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers collected nasal-wash samples from 11 preterm and 13 full-term babies in hospital with RSV bronchiolitis and compared their illness severity and immune responses.

What They Found

This pilot study found that preterm infants hospitalized with RSV bronchiolitis had lower nasal-wash white blood cell counts and a weaker interleukin-8 response than term infants, with 11 preterm and 13 term infants studied. Illness severity score, oxygen saturation on admission, and days on extra oxygen did not differ significantly between the groups. White cell counts and interleukin-8 levels were higher in term infants. In term infants, these levels went up with higher severity scores (p less than 0.05), but not in preterm infants (p greater than 0.05). Levels of interleukin-4 and interferon-gamma did not differ between the groups (p greater than 0.05).

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a small pilot study of 24 infants, and the abstract reports only associations in a single group of hospitalized infants, so it cannot show why the immune responses differed.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Pilot Study
Category Uncategorised
Source Pubmed
PubMed ID 21683109
Year Published 2011
Journal Human immunology
MeSH Terms Bronchiolitis, Viral; Cell Count; Cell Proliferation; Cells, Cultured; Disease Progression; Female; Hospitalization; Humans; Hyperbaric Oxygenation; Immunity, Cellular; Infant, Newborn; Interleukin-8; Leukocytes, Mononuclear; Nasal Mucosa; Oxygen Consumption

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology